Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,868 | -14,260 | -10,879 | -8,614 | -4,122 |
| Depreciation Amortization | -57 | 92 | 95 | 72 | 53 |
| Other Working Capital | -240 | -612 | -992 | 1,383 | 264 |
| Other Operating Activity | 408 | 2,012 | 1,678 | 1,099 | 477 |
| Operating Cash Flow | $-3,757 | $-12,768 | $-10,099 | $-6,060 | $-3,328 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -952 | 207 | -403 | -335 | 177 |
| PPE Investments | -9 | -28 | -21 | -14 | N/A |
| Investing Cash Flow | $-961 | $179 | $-424 | $-349 | $177 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 300 | 300 | 300 | 300 |
| Common Stock Repurchased | N/A | -2,482 | -2,482 | -2,482 | -2,482 |
| Financing Cash Flow | $N/A | $-2,183 | $-2,183 | $-2,183 | $-2,183 |
| Exchange Rate Effect | -5 | -11 | -21 | -28 | 2 |
| Beginning Cash Position | 37,743 | 52,524 | 52,524 | 52,524 | 52,524 |
| End Cash Position | 33,020 | 37,743 | 39,799 | 43,904 | 47,193 |
| Net Cash Flow | $-4,723 | $-14,781 | $-12,725 | $-8,620 | $-5,331 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,757 | -12,768 | -10,099 | -6,060 | -3,328 |
| Capital Expenditure | -9 | -28 | -21 | -14 | N/A |
| Free Cash Flow | -3,766 | -12,795 | -10,120 | -6,075 | -3,328 |